September 25, 2023
Zucara Therapeutics Doses First Patient in Phase 2a ‘ZONE’ Trial
June 15, 2023
Zucara Therapeutics Announces Additional Funding from JDRF to Support ZT-01 Phase 2 Study
September 19, 2022
Zucara Therapeutics Positive Proof of Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01
No current content.